Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Pediatric Dental Market Snapshot (2022 to 2032)

Newly-released Pediatric Dental industry analysis report by Future Market Insights shows that global sales of Pediatric Dental in 2021 were held at US$ 9.6 Billion. With a CAGR of 7.4% from 2022 to 2032, the market is projected to reach a valuation of US$ 20.9 Billion by 2032. Market revenue through Dental Caries is expected to gross the highest revenue, accounting for an absolute dollar opportunity of nearly US$ 10.6 Billion from 2022 to 2032.

Attribute Details
Global Pediatric Dental Market (2022) US$ 10.3 Billion
Global Pediatric Dental Market (2032) US$ 20.9 Billion
Global Pediatric Dental Market CAGR (2022 to 2032) 7.4%
USA Pediatric Dental Market (2022 to 2032) 6.3%
Key Companies Profiled
  • 3M
  • Hu-Friedy Mfg. Co., LLC
  • Kinder Krowns
  • Figaro Crowns, Inc.
  • Acero Crowns
  • Sprig Oral Health Technologies, Inc.
  • Edelweiss Dentistry Products GmbH
  • SML
  • Cheng Crowns
  • Dentsply Sirona

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Revenue of Pediatric Dental from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the Pediatric Dental industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Pediatric Dental industry increased at around 6.2% CAGR, wherein, countries such as the USA, UK, China, Japan, and South Korea held a significant share in the global market. Owing to this, the pediatric dental market is projected to grow at a CAGR of 7.4% over the coming 10 years.

What factors are leading to the growth of the Pediatric Dental industry?

The advancement in technology of dental operations can be credited to the pediatric dental market's growth. Some of the children develop a dental fear that necessitates sedation dentistry as a safe and effective treatment option. Nitrous oxide is a type of general anesthesia that is increasingly being utilized in children's dentistry.

Pain-free mouth injections are used in pediatric dentistry to enhance the patient experience. The instruments and approaches are used to assist children to feel less pain and have less dental fear. This approach provides for faster treatments and higher patient cooperation.

Many people prefer a minimally invasive technique because of its advantages. CariVu, varnish, dental sealants, fluoride, and digital X-rays are examples of chemicals that can either intervene before restorative treatment or avoid dental disorders entirely. One of the noticeable developments in pediatric dentistry is the shift toward preventative care.

The American Academy of Pediatric Dentistry (AAPD) predicts that the growing number of pediatric dentists in America will boost by more than 60% within the next decade. Based on AAPD, the overall number of pediatric dentists practicing in the US has roughly doubled since 2001. Dental work as a pediatric dentist is anticipated to remain solid in the years to come, hence the industry's growth.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Region Carries Significant Potential in Pediatric Dental Market?

Over the projection period, Asia Pacific is expected to be the fastest-growing regional market. In the recent past, dental problems have gained significant attention in the Asia-Pacific countries. The surge in urbanization has led to the increasing expenditure of people on dental health. Besides, major players' investments in developing countries like China and India have boosted consumer confidence. In addition, the increasing prevalence of oral health diseases is expected to drive regional market expansion in the next years.

Country-wise Analysis

USA Pediatric Dental Market Analysis

With a market share of more than 35% in 2021, the USA dominated the pediatric dental market. The vast patient base needed to fix varied dental health issues has ensured the success of dental work throughout the globe, like in the USA, and has contributed to the development of the healthcare ecosystem in many countries. According to Richmond Dental and Medical, the USA has 196,000 dentists. With the constant surge in the number of dental practitioners, the market in the country is expected to flourish in the forthcoming years.

UK Pediatric Dental Market Analysis

The market in the UK is expected to reach a valuation of US$ 1.1 Billion by 2032. From 2022 to 2032, the market in the country is expected to gross an absolute dollar opportunity of US$ 561 Million, growing at a CAGR of 7.9%.

Japan Pediatric Dental Market Analysis

In Japan, the market is projected to reach US$ 848 Million by 2032, growing at a CAGR of 8% from 2022 to 2032. During the forecast period, the market is expected to gross an absolute dollar opportunity of US$ 457 Million.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Why Pediatric Dental Market through Dental Caries accounts for a Large Share?

With a share of revenue of more than 35% in 2021, the dental caries category led the market. The disarray among deciduous teeth is the result of more substantial dental problems. Infections, persistent pain, and other symptoms arise from dental caries in children. The condition of a kid's teeth at an early age affects his ability to discover social and emotional control. The need for treatment is likely to increase, as children get older. It will only be necessary to apply the remedy periodically to avoid an unhealthy lifestyle, and the affliction is projected to grow with future generations.

Dentists prefer to apply diet fluoride supplementation and fluoride varnish to the teeth of children who are at significant risk of dental caries as a preventive measure. Fluoride supplementation should be taken exactly as dental practitioners recommend. Early Childhood development of caries is a sugar-driven, multifactorial, bacterial-mediated kind of caries that causes phasic demineralization and remineralization of hard dental tissue. The therapy of early childhood caries (ECC) is expected to drive market expansion.

Why is Market Revenue through Dental Cleaning Procedure Expected to Gross Significant Revenue?

With a market share of more than 30% in 2021, the dental cleaning (prophylaxis) category led the market. The increase in the number of dental procedures carried out in dental facilities and hospitals is due to the rise in the number of dental prophylaxis treatments. Plaque that is untreatable through mass tooth brushing is removed with dental prophylaxis. The teeth must be cleaned at recurring intervals of about 8 to 16 weeks. This is more frequent for patients unable to clean their teeth themselves.

A yearly mouth debridement may be needed due to the accumulation of tartar. Hand tools, such as a micro-ultrasonic scaler are used during the procedure. Various antimicrobial treatments, periodontal disinfection, desensitizing gels, and full-mouth debridements are a few of the dental procedures available. Demand for such procedures is rising, due chiefly to a rise in oral hygiene problems, which will boost the segment's growth.

Malocclusion is a global dental issue that is on the rise. The most frequent dental problems encountered in children that are significantly associated with malocclusion are pulpal, dental trauma, dental caries, periapical lesions, oral habits, and developmental abnormalities. The segment's growth is expected to be boosted by the diagnosis and treatment of the condition.

In young toddlers with primary teeth, dental trauma is a regular occurrence. The greater physical mobility that comes with learning to walk and run is a big reason for this. Mandibular primary teeth are less vulnerable to trauma than anterior maxillary primary teeth. The most prevalent types of primary tooth injuries include luxation, avulsion, and crown fracture. The segment's expansion is likely to be fueled by the growing problem of dental trauma.

Competitive Analysis

The market is fiercely competitive, with a large number of domestic and international companies. The key players operating in the market are 3M, Hu-Friedy Mfg. Co., LLC, Kinder Krowns, Figaro Crowns, Inc., Acero Crowns, Sprig Oral Health Technologies, Inc., Edelweiss Dentistry Products GmbH, SML, Cheng Crowns, and Dentsply Sirona.

Some of the recent developments of key Pediatric Dental providers are as follows:

  • In June 2021, Spark Clear Aligner System obtained FDA approval for younger patients. The company's revenue is expected to improve as a result of this approval.
  • In March 2020, Ivoclar Vivadent will offer Ivotion, a monolithic, single-disc milling machine. Ivotion is a bicolor disc that combines high-quality tooth and denture foundation components into a single product. It provides a monolithic milling solution that is both efficient and predictable for digital laboratories. Ivoclar Vivadent's digital denture solutions are integrated into the Ivotion Denture System with the advent of the ivotion disc.
  • In September 2019, Dentsply Sirona and Carbon announced the launch of Lucitone Digital Print Denture process and material system. The collaboration brings to market the world's first digitally created product, which is carved from carbon and made of Dentsply Sirona components. This technology will revolutionize digital dentistry due to its strength, attractiveness, and lab effectiveness for 3D-printed things.

Similarly, recent developments related to companies in Pediatric Dental Market have been tracked by the team at Future Market Insights, which are available in the full report.

Market Segments Covered in Pediatric Dental Industry Analysis

By Disease Type :

  • Dental Caries
  • Enamel Disorders
  • Other Disease Types

By Type :

  • Primary
  • Permanent

By Procedure :

  • Pulpotomies
  • Stainless Steel Crowns (SSCs)
  • Tooth-Colored Fillings
  • Dental Cleaning (Prophylaxis)
  • Other Procedures

By Region :

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

How much is the current worth of the Pediatric Dental market?

The global Pediatric Dental market is worth more than US$ 10.3 Billion at present.

What is the sales forecast for Pediatric Dental?

The value of Pediatric Dental is projected to increase at a CAGR of around 7.4% from 2022 to 2032.

What was the last 5 year’s market CAGR?

The value of Pediatric Dental increased at a CAGR of around 6.2% from 2017 to 2021.

What are the top five players in the Pediatric Dental market?

The top five players in Pediatric Dental market include 3M, Figaro Crowns, Hu-Friedy, Kinder Krowns, and Sprig Oral Health Technologies.

Which are the top 5 countries driving demand for Pediatric Dental?

The top 5 countries driving demand for Pediatric Dental are the USA, the UK, China, Japan, and South Korea

What is the outlook for the market in Asia Pacific?

Asia Pacific accounted for over 45% of global Pediatric Dental demand in 2021.

At what percentage is sales of Pediatric Dental going to register growth in Europe?

The European market for Pediatric Dental is projected to expand at a CAGR of around 19% from 2022 to 2032.

Table of Content

1. Executive Summary | Pediatric Dental Market

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Million)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. Market, by Key Countries

    4.2. Market Opportunity Assessment (US$ Million)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Patch Management Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Patch Management Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global Market Demand Analysis 2017 to 2021 and Forecast, 2022 to 2032

    6.1. Historical Market Analysis, 2017 to 2021

    6.2. Current and Future Market Projections, 2022 to 2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2032

    7.1. Historical Market Value (US$ Million) Analysis, 2017 to 2021

    7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Disease Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Million) Analysis By Disease Type, 2017 to 2021

    8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Disease Type, 2022 to 2032

        8.3.1. Dental Caries

        8.3.2. Enamel Disorders

        8.3.3. Other Disease Types

    8.4. Market Attractiveness Analysis By Disease Type

9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) Analysis By Type, 2017 to 2021

    9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Type, 2022 to 2032

        9.3.1. Primary

        9.3.2. Permanent

    9.4. Market Attractiveness Analysis By Type

10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Procedure

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) Analysis By Procedure, 2017 to 2021

    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Procedure, 2022 to 2032

        10.3.1. Pulpotomies

        10.3.2. Stainless Steel Crowns

        10.3.3. Tooth-Colored Fillings

        10.3.4. Dental Cleaning

        10.3.5. Other Procedures

    10.4. Market Attractiveness Analysis By Procedure

11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2021

    11.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2022 to 2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. Asia Pacific

        11.3.5. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    12.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032

        12.4.1. By Country

            12.4.1.1. United States of America

            12.4.1.2. Canada

            12.4.1.3. Rest of North America

        12.4.2. By Disease Type

        12.4.3. By Procedure

        12.4.4. By Type

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Disease Type

        12.5.3. By Procedure

        12.5.4. By Type

13. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    13.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032

        13.4.1. By Country

            13.4.1.1. Brazil

            13.4.1.2. Mexico

            13.4.1.3. Rest of Latin America

        13.4.2. By Disease Type

        13.4.3. By Procedure

        13.4.4. By Type

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Disease Type

        13.5.3. By Procedure

        13.5.4. By Type

14. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    14.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032

        14.4.1. By Country

            14.4.1.1. Germany

            14.4.1.2. France

            14.4.1.3. United Kingdom

            14.4.1.4. Italy

            14.4.1.5. Benelux

            14.4.1.6. Nordic Countries

            14.4.1.7. Rest of Europe

        14.4.2. By Disease Type

        14.4.3. By Procedure

        14.4.4. By Type

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Disease Type

        14.5.3. By Procedure

        14.5.4. By Type

15. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    15.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032

        15.4.1. By Country

            15.4.1.1. China

            15.4.1.2. Japan

            15.4.1.3. South Korea

            15.4.1.4. Rest of Asia Pacific

        15.4.2. By Disease Type

        15.4.3. By Procedure

        15.4.4. By Type

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Disease Type

        15.5.3. By Procedure

        15.5.4. By Type

16. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    16.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032

        16.4.1. By Country

            16.4.1.1. GCC Countries

            16.4.1.2. South Africa

            16.4.1.3. Turkey

            16.4.1.4. Rest of Middle East and Africa

        16.4.2. By Disease Type

        16.4.3. By Procedure

        16.4.4. By Type

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Disease Type

        16.5.3. By Procedure

        16.5.4. By Type

17. Key Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2032

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. US Market Analysis

        17.2.1. Value Proportion Analysis by Market Taxonomy

        17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

            17.2.2.1. By Disease Type

            17.2.2.2. By Procedure

            17.2.2.3. By Type

    17.3. Canada Market Analysis

        17.3.1. Value Proportion Analysis by Market Taxonomy

        17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

            17.3.2.1. By Disease Type

            17.3.2.2. By Procedure

            17.3.2.3. By Type

    17.4. Mexico Market Analysis

        17.4.1. Value Proportion Analysis by Market Taxonomy

        17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

            17.4.2.1. By Disease Type

            17.4.2.2. By Procedure

            17.4.2.3. By Type

    17.5. Brazil Market Analysis

        17.5.1. Value Proportion Analysis by Market Taxonomy

        17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

            17.5.2.1. By Disease Type

            17.5.2.2. By Procedure

            17.5.2.3. By Type

    17.6. Germany Market Analysis

        17.6.1. Value Proportion Analysis by Market Taxonomy

        17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

            17.6.2.1. By Disease Type

            17.6.2.2. By Procedure

            17.6.2.3. By Type

    17.7. France Market Analysis

        17.7.1. Value Proportion Analysis by Market Taxonomy

        17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

            17.7.2.1. By Disease Type

            17.7.2.2. By Procedure

            17.7.2.3. By Type

    17.8. Italy Market Analysis

        17.8.1. Value Proportion Analysis by Market Taxonomy

        17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

            17.8.2.1. By Disease Type

            17.8.2.2. By Procedure

            17.8.2.3. By Type

    17.9. BENELUX Market Analysis

        17.9.1. Value Proportion Analysis by Market Taxonomy

        17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

            17.9.2.1. By Disease Type

            17.9.2.2. By Procedure

            17.9.2.3. By Type

    17.10. UK Market Analysis

        17.10.1. Value Proportion Analysis by Market Taxonomy

        17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

            17.10.2.1. By Disease Type

            17.10.2.2. By Procedure

            17.10.2.3. By Type

    17.11. Nordic Countries Market Analysis

        17.11.1. Value Proportion Analysis by Market Taxonomy

        17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

            17.11.2.1. By Disease Type

            17.11.2.2. By Procedure

            17.11.2.3. By Type

    17.12. China Market Analysis

        17.12.1. Value Proportion Analysis by Market Taxonomy

        17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

            17.12.2.1. By Disease Type

            17.12.2.2. By Procedure

            17.12.2.3. By Type

    17.13. Japan Market Analysis

        17.13.1. Value Proportion Analysis by Market Taxonomy

        17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

            17.13.2.1. By Disease Type

            17.13.2.2. By Procedure

            17.13.2.3. By Type

    17.14. South Korea Market Analysis

        17.14.1. Value Proportion Analysis by Market Taxonomy

        17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

            17.14.2.1. By Disease Type

            17.14.2.2. By Procedure

            17.14.2.3. By Type

    17.15. GCC Countries Market Analysis

        17.15.1. Value Proportion Analysis by Market Taxonomy

        17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

            17.15.2.1. By Disease Type

            17.15.2.2. By Procedure

            17.15.2.3. By Type

    17.16. South Africa Market Analysis

        17.16.1. Value Proportion Analysis by Market Taxonomy

        17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

            17.16.2.1. By Disease Type

            17.16.2.2. By Procedure

            17.16.2.3. By Type

    17.17. Turkey Market Analysis

        17.17.1. Value Proportion Analysis by Market Taxonomy

        17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

            17.17.2.1. By Disease Type

            17.17.2.2. By Procedure

            17.17.2.3. By Type

        17.17.3. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies

    18.2. Market Concentration

    18.3. Market Share Analysis of Top Players

    18.4. Market Presence Analysis

        18.4.1. By Regional footprint of Players

        18.4.2. Product footprint by Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive

        19.3.1. 3M

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Sales Footprint

            19.3.1.4. Strategy Overview

        19.3.2. Figari Crowns

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Sales Footprint

            19.3.2.4. Strategy Overview

        19.3.3. Hu-friedy

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Sales Footprint

            19.3.3.4. Strategy Overview

        19.3.4. Kinder Crowns

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Sales Footprint

            19.3.4.4. Strategy Overview

        19.3.5. Sprig Oral Health Technologies

            19.3.5.1. Overview

            19.3.5.2. Product Portfolio

            19.3.5.3. Sales Footprint

            19.3.5.4. Strategy Overview

        19.3.6. Edelweiss Dentistry Products

            19.3.6.1. Overview

            19.3.6.2. Product Portfolio

            19.3.6.3. Sales Footprint

            19.3.6.4. Strategy Overview

        19.3.7. Acero Crowns

            19.3.7.1. Overview

            19.3.7.2. Product Portfolio

            19.3.7.3. Sales Footprint

            19.3.7.4. Strategy Overview

        19.3.8. SML

            19.3.8.1. Overview

            19.3.8.2. Product Portfolio

            19.3.8.3. Sales Footprint

            19.3.8.4. Strategy Overview

        19.3.9. Cheng Crowns

            19.3.9.1. Overview

            19.3.9.2. Product Portfolio

            19.3.9.3. Sales Footprint

            19.3.9.4. Strategy Overview

        19.3.10. Dentsply Sirona

            19.3.10.1. Overview

            19.3.10.2. Product Portfolio

            19.3.10.3. Sales Footprint

            19.3.10.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million), By Disease Type, 2017 to 2021

Table 2: Global Market Value (US$ Million), By Disease Type, 2022 to 2032

Table 3: Global Market Value (US$ Million), By Procedure, 2017 to 2021

Table 4: Global Market Value (US$ Million), By Procedure, 2022 to 2032

Table 5: Global Market Value (US$ Million), By Type, 2017 to 2021

Table 6: Global Market Value (US$ Million), By Type, 2022 to 2032

Table 7: Global Market, By Region, 2017 to 2021

Table 8: Global Market, By Region, 2022 to 2032

Table 9: North America Market Value (US$ Million), By Disease Type, 2017 to 2021

Table 10: North America Market Value (US$ Million), By Disease Type, 2022 to 2032

Table 11: North America Market Value (US$ Million), By Procedure, 2017 to 2021

Table 12: North America Market Value (US$ Million), By Procedure, 2022 to 2032

Table 13: North America Market Value (US$ Million), By Type, 2017 to 2021

Table 14: North America Market Value (US$ Million), By Type, 2022 to 2032

Table 15: North America Market, By Country, 2017 to 2021

Table 16: North America Market, By Country, 2022 to 2032

Table 17: Latin America Market Value (US$ Million), By Disease Type, 2017 to 2021

Table 18: Latin America Market Value (US$ Million), By Disease Type, 2022 to 2032

Table 19: Latin America Market Value (US$ Million), By Procedure, 2017 to 2021

Table 20: Latin America Market Value (US$ Million), By Procedure, 2022 to 2032

Table 21: Latin America Market Value (US$ Million), By Type, 2017 to 2021

Table 22: Latin America Market Value (US$ Million), By Type, 2022 to 2032

Table 23: Latin America Market, By Country, 2017 to 2021

Table 24: Latin America Market, By Country, 2022 to 2032

Table 25: Europe Market Value (US$ Million), By Disease Type, 2017 to 2021

Table 26: Europe Market Value (US$ Million), By Disease Type, 2022 to 2032

Table 27: Europe Market Value (US$ Million), By Procedure, 2017 to 2021

Table 28: Europe Market Value (US$ Million), By Procedure, 2022 to 2032

Table 29: Europe Market Value (US$ Million), By Type, 2017 to 2021

Table 30: Europe Market Value (US$ Million), By Type, 2022 to 2032

Table 31: Europe Market, By Country, 2017 to 2021

Table 32: Europe Market, By Country, 2022 to 2032

Table 33: Asia Pacific Market Value (US$ Million), By Disease Type, 2017 to 2021

Table 34: Asia Pacific Market Value (US$ Million), By Disease Type, 2022 to 2032

Table 35: Asia Pacific Market Value (US$ Million), By Procedure, 2017 to 2021

Table 36: Asia Pacific Market Value (US$ Million), By Procedure, 2022 to 2032

Table 37: Asia Pacific Market Value (US$ Million), By Type, 2017 to 2021

Table 38: Asia Pacific Market Value (US$ Million), By Type, 2022 to 2032

Table 39: Asia Pacific Market, By Country, 2017 to 2021

Table 40: Asia Pacific Market, By Country, 2022 to 2032

Table 41: MEA Market Value (US$ Million), By Disease Type, 2017 to 2021

Table 42: MEA Market Value (US$ Million), By Disease Type, 2022 to 2032

Table 43: MEA Market Value (US$ Million), By Procedure, 2017 to 2021

Table 44: MEA Market Value (US$ Million), By Procedure, 2022 to 2032

Table 45: MEA Market Value (US$ Million), By Type, 2017 to 2021

Table 46: MEA Market Value (US$ Million), By Type, 2022 to 2032

Table 47: MEA Market, By Country, 2017 to 2021

Table 48: MEA Market, By Country, 2022 to 2032

Table 49: Global Market Incremental $ Opportunity, By Disease Type, 2017 to 2021

Table 50: Global Market Incremental $ Opportunity, By Procedure, 2022 to 2032

Table 51: Global Market Incremental $ Opportunity, By Type, 2017 to 2021

Table 52: Global Market Incremental $ Opportunity, By Region, 2022 to 2032

Table 53: North America Market Incremental $ Opportunity, By Disease Type, 2017 to 2021

Table 54: North America Market Incremental $ Opportunity, By Procedure, 2022 to 2032

Table 55: North America Market Incremental $ Opportunity, By Type, 2017 to 2021

Table 56: North America Market Incremental $ Opportunity, By Country, 2022 to 2032

Table 57: Latin America Market Incremental $ Opportunity, By Disease Type, 2017 to 2021

Table 58: Latin America Market Incremental $ Opportunity, By Procedure, 2022 to 2032

Table 59: Latin America Market Incremental $ Opportunity, By Type, 2017 to 2021

Table 60: Latin America Market Incremental $ Opportunity, By Country, 2022 to 2032

Table 61: Europe Market Incremental $ Opportunity, By Disease Type, 2017 to 2021

Table 62: Europe Market Incremental $ Opportunity, By Procedure, 2022 to 2032

Table 63: Europe Market Incremental $ Opportunity, By Type, 2017 to 2021

Table 64: Europe Market Incremental $ Opportunity, By Country, 2022 to 2032

Table 65: Asia Pacific Market Incremental $ Opportunity, By Disease Type, 2017 to 2021

Table 66: Asia Pacific Market Incremental $ Opportunity, By Procedure, 2022 to 2032

Table 67: Asia Pacific Market Incremental $ Opportunity, By Type, 2017 to 2021

Table 68: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 to 2032

Table 69: MEA Market Incremental $ Opportunity, By Disease Type, 2017 to 2021

Table 70: MEA Market Incremental $ Opportunity, By Procedure, 2022 to 2032

Table 71: MEA Market Incremental $ Opportunity, By Type, 2017 to 2021

Table 72: MEA Market Incremental $ Opportunity, By Country, 2022 to 2032
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032

Figure 2: Global Market Absolute $ Historical Gain (2017 to 2021) and Opportunity (2022 to 2032), US$ Million

Figure 3: Global Market Share, By Disease Type, 2022 to 2032

Figure 4: Global Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032

Figure 5: Global Market Attractiveness Index, By Disease Type - 2022 to 2032

Figure 6: Global Market Share, By Procedure, 2022 to 2032

Figure 7: Global Market Y-o-Y Growth Projections, By Procedure - 2022 to 2032

Figure 8: Global Market Attractiveness Index, By Procedure - 2022 to 2032

Figure 9: Global Market Share, By Type, 2022 to 2032

Figure 10: Global Market Y-o-Y Growth Projections, By Type - 2022 to 2032

Figure 11: Global Market Attractiveness Index, By Type - 2022 to 2032

Figure 12: Global Market Share, By Region, 2022 to 2032

Figure 13: Global Market Y-o-Y Growth Projections, By Region - 2022 to 2032

Figure 14: Global Market Attractiveness Index, By Region - 2022 to 2032

Figure 15: North America Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032

Figure 16: North America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million

Figure 17: North America Market Share, By Disease Type, 2022 to 2032

Figure 18: North America Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032

Figure 19: North America Market Attractiveness Index, By Disease Type - 2022 to 2032

Figure 20: North America Market Share, By Procedure, 2022 to 2032

Figure 21: North America Market Y-o-Y Growth Projections, By Procedure - 2022 to 2032

Figure 22: North America Market Attractiveness Index, By Procedure - 2022 to 2032

Figure 23: North America Market Share, By Type, 2022 to 2032

Figure 24: North America Market Y-o-Y Growth Projections, By Type - 2022 to 2032

Figure 25: North America Market Attractiveness Index, By Type - 2022 to 2032

Figure 26: North America Market Share, By Country, 2022 to 2032

Figure 27: North America Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 28: North America Market Attractiveness Index, By Country - 2022 to 2032

Figure 29: Latin America Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032

Figure 30: Latin America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million

Figure 31: Latin America Market Share, By Disease Type, 2022 to 2032

Figure 32: Latin America Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032

Figure 33: Latin America Market Attractiveness Index, By Disease Type - 2022 to 2032

Figure 34: Latin America Market Share, By Procedure, 2022 to 2032

Figure 35: Latin America Market Y-o-Y Growth Projections, By Procedure - 2022 to 2032

Figure 36: Latin America Market Attractiveness Index, By Procedure - 2022 to 2032

Figure 37: Latin America Market Share, By Type, 2022 to 2032

Figure 38: Latin America Market Y-o-Y Growth Projections, By Type - 2022 to 2032

Figure 39: Latin America Market Attractiveness Index, By Type - 2022 to 2032

Figure 40: Latin America Market Share, By Country, 2022 to 2032

Figure 41: Latin America Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 42: Latin America Market Attractiveness Index, By Country - 2022 to 2032

Figure 43: Europe Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032

Figure 44: Europe Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million

Figure 45: Europe Market Share, By Disease Type, 2022 to 2032

Figure 46: Europe Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032

Figure 47: Europe Market Attractiveness Index, By Disease Type - 2022 to 2032

Figure 48: Europe Market Share, By Procedure, 2022 to 2032

Figure 49: Europe Market Y-o-Y Growth Projections, By Procedure - 2022 to 2032

Figure 50: Europe Market Attractiveness Index, By Procedure - 2022 to 2032

Figure 51: Europe Market Share, By Type, 2022 to 2032

Figure 52: Europe Market Y-o-Y Growth Projections, By Type - 2022 to 2032

Figure 53: Europe Market Attractiveness Index, By Type - 2022 to 2032

Figure 54: Europe Market Share, By Country, 2022 to 2032

Figure 55: Europe Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 56: Europe Market Attractiveness Index, By Country - 2022 to 2032

Figure 57: MEA Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032

Figure 58: MEA Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million

Figure 59: MEA Market Share, By Disease Type, 2022 to 2032

Figure 60: MEA Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032

Figure 61: MEA Market Attractiveness Index, By Disease Type - 2022 to 2032

Figure 62: MEA Market Share, By Procedure, 2022 to 2032

Figure 63: MEA Market Y-o-Y Growth Projections, By Procedure - 2022 to 2032

Figure 64: MEA Market Attractiveness Index, By Procedure - 2022 to 2032

Figure 65: MEA Market Share, By Type, 2022 to 2032

Figure 66: MEA Market Y-o-Y Growth Projections, By Type - 2022 to 2032

Figure 67: MEA Market Attractiveness Index, By Type - 2022 to 2032

Figure 68: MEA Market Share, By Country, 2022 to 2032

Figure 69: MEA Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 70: MEA Market Attractiveness Index, By Country - 2022 to 2032

Figure 71: Asia Pacific Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032

Figure 72: Asia Pacific Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million

Figure 73: Asia Pacific Market Share, By Disease Type, 2022 to 2032

Figure 74: Asia Pacific Market Y-o-Y Growth Projections, By Disease Type - 2022 to 2032

Figure 75: Asia Pacific Market Attractiveness Index, By Disease Type - 2022 to 2032

Figure 76: Asia Pacific Market Share, By Procedure, 2022 to 2032

Figure 77: Asia Pacific Market Y-o-Y Growth Projections, By Procedure - 2022 to 2032

Figure 78: Asia Pacific Market Attractiveness Index, By Procedure - 2022 to 2032

Figure 79: Asia Pacific Market Share, By Type, 2022 to 2032

Figure 80: Asia Pacific Market Y-o-Y Growth Projections, By Type - 2022 to 2032

Figure 81: Asia Pacific Market Attractiveness Index, By Type - 2022 to 2032

Figure 82: Asia Pacific Market Share, By Country, 2022 to 2032

Figure 83: Asia Pacific Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 84: Asia Pacific Market Attractiveness Index, By Country - 2022 to 2032

Figure 85: US Market Value (US$ Million) and Forecast, 2022 to 2032

Figure 86: US Market Share, By Disease Type, 2021

Figure 87: US Market Share, By Procedure, 2021

Figure 88: US Market Share, By Type, 2021

Figure 89: Canada Market Value (US$ Million) and Forecast, 2022 to 2032

Figure 90: Canada Market Share, By Disease Type, 2021

Figure 91: Canada Market Share, By Procedure, 2021

Figure 92: Canada Market Share, By Type, 2021

Figure 93: Brazil Market Value (US$ Million) and Forecast, 2022 to 2032

Figure 94: Brazil Market Share, By Disease Type, 2021

Figure 95: Brazil Market Share, By Procedure, 2021

Figure 96: Brazil Market Share, By Type, 2021

Figure 97: Mexico Market Value (US$ Million) and Forecast, 2022 to 2032

Figure 98: Mexico Market Share, By Disease Type, 2021

Figure 99: Mexico Market Share, By Procedure, 2021

Figure 100: Mexico Market Share, By Type, 2021

Figure 101: Germany Market Value (US$ Million) and Forecast, 2022 to 2032

Figure 102: Germany Market Share, By Disease Type, 2021

Figure 103: Germany Market Share, By Procedure, 2021

Figure 104: Germany Market Share, By Type, 2021

Figure 105: UK Market Value (US$ Million) and Forecast, 2022 to 2032

Figure 106: UK Market Share, By Disease Type, 2021

Figure 107: UK Market Share, By Procedure, 2021

Figure 108: UK Market Share, By Type, 2021

Figure 109: France Market Value (US$ Million) and Forecast, 2022 to 2032

Figure 110: France Market Share, By Disease Type, 2021

Figure 111: France Market Share, By Procedure, 2021

Figure 112: France Market Share, By Type, 2021

Figure 113: Italy Market Value (US$ Million) and Forecast, 2022 to 2032

Figure 114: Italy Market Share, By Disease Type, 2021

Figure 115: Italy Market Share, By Procedure, 2021

Figure 116: Italy Market Share, By Type, 2021

Figure 117: BENELUX Market Value (US$ Million) and Forecast, 2022 to 2032

Figure 118: BENELUX Market Share, By Disease Type, 2021

Figure 119: BENELUX Market Share, By Procedure, 2021

Figure 120: BENELUX Market Share, By Type, 2021

Figure 121: Nordic Countries Market Value (US$ Million) and Forecast, 2022 to 2032

Figure 122: Nordic Countries Market Share, By Disease Type, 2021

Figure 123: Nordic Countries Market Share, By Procedure, 2021

Figure 124: Nordic Countries Market Share, By Type, 2021

Figure 125: China Market Value (US$ Million) and Forecast, 2022 to 2032

Figure 126: China Market Share, By Disease Type, 2021

Figure 127: China Market Share, By Procedure, 2021

Figure 128: China Market Share, By Type, 2021

Figure 129: Japan Market Value (US$ Million) and Forecast, 2022 to 2032

Figure 130: Japan Market Share, By Disease Type, 2021

Figure 131: Japan Market Share, By Procedure, 2021

Figure 132: Japan Market Share, By Type, 2021

Figure 133: South Korea Market Value (US$ Million) and Forecast, 2022 to 2032

Figure 134: South Korea Market Share, By Disease Type, 2021

Figure 135: South Korea Market Share, By Procedure, 2021

Figure 136: South Korea Market Share, By Type, 2021

Figure 137: GCC Countries Market Value (US$ Million) and Forecast, 2022 to 2032

Figure 138: GCC Countries Market Share, By Disease Type, 2021

Figure 139: GCC Countries Market Share, By Procedure, 2021

Figure 140: GCC Countries Market Share, By Type, 2021

Figure 141: South Africa Market Value (US$ Million) and Forecast, 2022 to 2032

Figure 142: South Africa Market Share, By Disease Type, 2021

Figure 143: South Africa Market Share, By Procedure, 2021

Figure 144: South Africa Market Share, By Type, 2021

Figure 145: Turkey Market Value (US$ Million) and Forecast, 2022 to 2032

Figure 146: Turkey Market Share, By Disease Type, 2021

Figure 147: Turkey Market Share, By Procedure, 2021

Figure 148: Turkey Market Share, By Type, 2021

Explore Healthcare Insights

View Reports